Mar 1, 2019 ... ... as to Aktiebolaget Hassle on 3/1/2019; AstraZeneca AB on 3/1/2019; AstraZeneca Pharmaceuticals LP on 3/1/2019; Zeneca Inc. on 3/1/2019.
Parties, docket activity and news coverage of federal case Cipla Limited et al v. AstraZeneca AB et al, case number 1:19-cv-00438, from Delaware Court. ... Defendant. AstraZeneca Pharmaceuticals LP ...
Jun 19, 2013 ... Deborah BRANGMAN, Plaintiff, v. ... Partners, LP, et al., Defendants. ..... AstraZeneca terminated Brangman because she was no longer on ...
AstraZeneca Pharmaceuticals LP and AstraZeneca Pharmaceuticals UK Ltd. ( collectively, .... [as long as it] fulfils [sic] the function of preventing significant growth of ..... See J. Roger Hart et al.,Chelating Agents As Preservative Potentiators, ...
Case opinion for US 3rd Circuit EMORY v. ... EMORY v. ... Moving for summary judgment, AstraZeneca urged that Emory's substantive claims ... In all, Emory bid unsuccessfully for approximately ten internal promotions over .... C. § 720 et seq. .... (iii) The permanent or long term impact, or the expected permanent or long term ...
Aug 2, 2017 ... possibly all) of these medications no longer have patent protection. .... LEAR v. ASTRAZENECA PHARMACEUTICALS LP, ET AL., C.A. No.
Hunt, et al. v. Merck-Medco Managed Care L.L. C., No. 00-CV-737 (E.D. Pa.) ( hereinafter .... et al. v. AstraZeneca LP, C.A. No. ... Exhibit 18 is 118 pages long.
Emory v. AstraZeneca Pharmaceuticals LP, 401 F.3d 174 (3/2005) Alvin "Rob" ... notwithstanding the agreement of all relevant parties that they no longer require .... under the Americans with Disabilities Act ("ADA"), 42 U.S.C. § 12101 et seq.
Feb 11, 2015 ... DiMattia et al. v. AstraZeneca LP et al. No. 10-910 (D. Del.). The claims settled by this agreement are allegations only; there has been no ...